Drug intelligence / Profile preview

doxycycline

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Doxycycline is a broad-spectrum tetracycline antibiotic used to treat a wide variety of bacterial infections caused by both gram-positive and gram-negative organisms. It is also indicated for the treatment or prevention of anthrax (including inhalational anthrax), plague and tularemia (potential bioterrorism agents), rickettsial infections (such as Rocky Mountain spotted fever and typhus), sexually transmitted infections (including chlamydia and gonorrhea), respiratory tract infections (such as those caused by Mycoplasma pneumoniae and Haemophilus influenzae), urinary tract infections due to susceptible bacteria such as Escherichia coli and Klebsiella species; ophthalmic infections; acne; rosacea; gum disease; malaria prophylaxis; and certain rare or resistant bacterial diseases. Mechanistically it works by inhibiting protein synthesis in bacteria through binding to the 30S ribosomal subunit. This action prevents the addition of amino acids to growing peptide chains during translation. Doxycycline also exhibits anti-inflammatory effects that contribute to its efficacy in conditions like acne and rosacea. It is available in several salt forms including doxycycline hyclate and monohydrate. Dosage forms include tablets (immediate- or delayed-release), capsules (immediate- or extended-release), oral suspension/powder for suspension/syrup/gel/injection. Developed by Pfizer.

Brand names
ActiclateAdoxaAdoxa CKAdoxa PakAdoxa TTAlodoxDoryxDoryx MPCMonodoxOraceaPeriostatVibramycin CalciumVibramycin HyclateVibra-TabsVibramycin-DEfracea
Other names
doxycycline hyclatedoxycycline monohydrate
02

Targets

Bacterial Ribosome

Beyond the preview

Go deeper on doxycycline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on doxycycline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call